Valuation : Accuray Incorporated

Market Cap 29.87M 25.7M 24.2M 22.05M 41.26M 2.84B 41.43M 287M 111M 1.45B 112M 110M 4.59B P/E 2027 *
-0.83x
P/E 2028 * -
Enterprise Value 29.87M 25.7M 24.2M 22.05M 41.26M 2.84B 41.43M 287M 111M 1.45B 112M 110M 4.59B EV / Sales 2027 *
0.07x
EV / Sales 2028 * -
Free-Float
93.21%
Yield 2027 *
-
Yield 2028 * -
1 day-4.54%
1 week-3.81%
Current month-4.90%
1 month-12.25%
3 months-25.32%
6 months-49.02%
Current year-69.67%
1 week 0.25
Extreme 0.25
0.28
1 month 0.25
Extreme 0.25
0.34
Current year 0.22
Extreme 0.22
0.93
1 year 0.22
Extreme 0.22
2.1
3 years 0.22
Extreme 0.22
3.1
5 years 0.22
Extreme 0.22
5.93
10 years 0.22
Extreme 0.22
6.39
Manager TitleAgeSince
Chief Executive Officer 67 19/10/2025
Director of Finance/CFO 46 08/05/2022
Chief Tech/Sci/R&D Officer - 31/08/2023
Director TitleAgeSince
Chairman 68 31/12/2020
Director/Board Member 65 05/09/2019
Director/Board Member 62 16/08/2021
Date Insider Type Main position Quantity % Market Cap. Importance
29/05/26 Free

Executive/Senior Manager

650,000 0.5472%
19/05/26
TCW Asset Management Co. LLC
OthersCompany 3,474,107 2.9248%
17/04/26
TCW Asset Management Co. LLC
OtherCompany 15,467,952 13.0221%
Change 5-day change 1-year change 3-year change Capi.($)
-4.54%-3.81%-84.37%-90.49% 29.87M
+0.44%-0.47%+25.56%+16.87% 224B
-0.19%-2.41%+5.41%-17.52% 144B
+0.88%-5.01%-24.45%+18.45% 125B
-0.04%-7.05%-58.41%-16.54% 65.16B
+0.30%-0.62%-20.11%-14.78% 50.05B
-0.62%-5.11%+7.99%+16.35% 49.67B
-1.43%-4.39%+14.65%+26.98% 40.81B
+0.47%-1.79%+34.70%+53.59% 39.77B
-2.87%-3.87%+108.72%+29.45% 30.96B
Average -0.81%-2.59%+0.97%+2.24% 76.92B
Weighted average by Cap. +0.01%-2.29%+5.69%+8.70%

Financials

2027 *2028 *
Net sales 413M 355M 335M 305M 570M 39.3B 573M 3.97B 1.53B 20.02B 1.55B 1.52B 63.43B -
Net income -37.9M -32.61M -30.71M -27.98M -52.35M -3.61B -52.56M -364M -141M -1.84B -142M -139M -5.82B -
Net Debt - -
Logo Accuray Incorporated
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Employees
809
Date Price Change Volume
09/09/26 US$0.2501 -4.54% 359,580
08/09/26 US$0.2620 -1.80% 433,724
04/09/26 US$0.2668 +0.30% 291,811
03/09/26 US$0.2660 +2.31% 247,973
02/09/26 US$0.2600 +2.12% 323,804
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.2501USD
Average target price
0.3500USD
Spread / Average Target
+39.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARAY Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!